3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
5
Completed
5
Recruiting
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
14
Thoracic
3
Breast
3
Gynecologic
2
Gastrointestinal
2
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
173
Head and Neck Neoplasms
141
Thyroid Neoplasms
59
Carcinoma, Non-Small-Cell Lung
58
Oropharyngeal Neoplasms
48
Melanoma
47
Nasopharyngeal Carcinoma
45
Colorectal Neoplasms
33
Mouth Neoplasms
30
Carcinoma, Renal Cell
29
Breast Neoplasms
27
Uterine Cervical Neoplasms
26
Neoplasms
26
Ovarian Neoplasms
25
Stomach Neoplasms
24
Carcinoma, Squamous Cell
23
Lung Neoplasms
22
Esophageal Neoplasms
22
Triple Negative Breast Neoplasms
20
Neoplasm Metastasis
20
Endometrial Neoplasms
20
Salivary Gland Neoplasms
19
Thyroid Cancer, Papillary
16
Pancreatic Neoplasms
16
Sarcoma
15
Laryngeal Neoplasms
15
Urinary Bladder Neoplasms
13
Prostatic Neoplasms
13
Colonic Neoplasms
13
Carcinoma, Transitional Cell
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Urologic Neoplasms
×
Head & Neck
×
Clear all
NCT06238479
2026-05-22
EXCEED
Eli Lilly and Company
Phase 1
Active not recruiting
490 enrolled